Atlas Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.48M | Sell |
1,899
-77
| -4% | -$60K | 0.18% | 101 |
|
2025
Q1 | $1.63M | Hold |
1,976
| – | – | 0.2% | 96 |
|
2024
Q4 | $1.53M | Sell |
1,976
-33
| -2% | -$25.5K | 0.19% | 92 |
|
2024
Q3 | $1.78M | Hold |
2,009
| – | – | 0.27% | 78 |
|
2024
Q2 | $1.82M | Sell |
2,009
-391
| -16% | -$354K | 0.24% | 85 |
|
2024
Q1 | $1.87M | Sell |
2,400
-82
| -3% | -$63.8K | 0.29% | 74 |
|
2023
Q4 | $1.45M | Sell |
2,482
-7
| -0.3% | -$4.08K | 0.21% | 83 |
|
2023
Q3 | $1.34M | Sell |
2,489
-725
| -23% | -$389K | 0.22% | 86 |
|
2023
Q2 | $1.51M | Sell |
3,214
-106
| -3% | -$49.7K | 0.23% | 83 |
|
2023
Q1 | $1.14M | Sell |
3,320
-264
| -7% | -$90.7K | 0.18% | 94 |
|
2022
Q4 | $1.31M | Sell |
3,584
-174
| -5% | -$63.7K | 0.22% | 91 |
|
2022
Q3 | $1.22M | Buy |
3,758
+121
| +3% | +$39.1K | 0.22% | 89 |
|
2022
Q2 | $1.18M | Sell |
3,637
-893
| -20% | -$290K | 0.2% | 94 |
|
2022
Q1 | $1.3M | Buy |
4,530
+2,061
| +83% | +$590K | 0.2% | 99 |
|
2021
Q4 | $682K | Sell |
2,469
-3,468
| -58% | -$958K | 0.1% | 173 |
|
2021
Q3 | $1.37M | Buy |
5,937
+5,830
| +5,449% | +$1.35M | 0.22% | 92 |
|
2021
Q2 | $24.6K | Buy |
107
+42
| +65% | +$9.64K | ﹤0.01% | 628 |
|
2021
Q1 | $12.1K | Buy |
+65
| New | +$12.1K | ﹤0.01% | 651 |
|